FDA Drug recall D-100-2013
Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenand…
- FDA Drug
- Class II
- terminated
- Published 2013-01-02
On 2013-01-02 the FDA classified a Class II recall of Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenand… by Lloyd, citing subpotent; 9-month stability interval.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-100-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2012-07-25 |
| Published | 2013-01-02 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Lloyd |
| Distribution | US |
Product
Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Reason
Subpotent; 9-month stability interval
Identifiers
| code_info | Lot HB23111 and HC23111 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-100-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.